Erivedge
Erivedge is the brand name for vismodegib which is a drug used to treat advanced basal cell carcinoma that has spread to other parts of the body or has come back after surgery.
Pronunciation[edit | edit source]
AYR-ih-vej
Indications[edit | edit source]
It is also used in patients with advanced basal cell carcinoma who cannot be treated with surgery or radiation therapy.
Other cancers[edit | edit source]
It is also being studied in the treatment of other types of cancer.
Mechanism of action[edit | edit source]
Erivedge blocks a type of protein involved in tissue growth and repair and may block the growth of cancer cells.
Classification[edit | edit source]
It is a type of Hedgehog signaling pathway antagonist.
Other names[edit | edit source]
Also called GDC-0449 and vismodegib.
External links[edit | edit source]
| Erivedge Resources | ||
|---|---|---|
|
| |
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Bonnu, Prab R. Tumpati, MD
